Aralov Andrey | Nucleic Acids Biochemistry | Best Researcher Award 

Prof. Aralov Andrey | Nucleic Acids Biochemistry | Best Researcher Award 

Prof. Aralov Andrey | IBCH RAS | Russia

Prof. Aralov Andrey holds a PhD (2011) in the chemical synthesis of natural and modified oligonucleotides using the phosphotriester method and currently serves as the Head of the Group of Molecular Tools for Living System Studies at the Institute of Bioorganic Chemistry, Russian Academy of Sciences (since 2018). Since 2013, he has curated and executed multiple competitive grants funded by the Russian Scientific Foundation for Basic Research and the Russian Science Foundation, contributing extensively to innovations in nucleic acid chemistry, molecular tools, aptamers, pH-responsive sensors, antiviral nucleosides, red-light fluorescent systems, and genomic DNA i-motif technologies. He is the author of more than seventy publications indexed in Scopus and Web of Science, with a strong track record in high-impact journals including Nucleic Acids Research, Sensors and Actuators B: Chemical, Current Issues in Molecular Biology, ACS Sensors, Nature Communications, Biosensors and Bioelectronics, and others. His notable works span DNA aptamer architectures with high affinity for influenza A virus, diversification of i-motif-based pH sensors, advances in nucleoside antiviral mechanisms, Mango-based red-light RNA tracking systems, ratiometric i-motif long-term pH monitoring tools, mechanistic studies of oxidized DNA lesions, and cell-free prototyping strategies for therapeutic peptides and proteins. His research outputs have been cited 548 times across 396 documents, reflecting his significant impact in the fields of nucleic acid chemistry and molecular biosensing, with an h-index of 14. In addition to his research achievements, he has authored several postgraduate-level courses on nucleic acid chemistry, contributing to advanced scientific training in the field.

Profiles: Scopus | Orcid | Staff Page

Featured Publications

Boldinova, E. O., Kruchinin, A. A., Kamzeeva, P. N., Aralov, A. V., & Makarova, A. V. (2025). Accurate DNA synthesis across 8-oxoadenine by human PrimPol. International Journal of Molecular Sciences, 26(14), 6796.

Kamzeeva, P. N., Alferova, V. A., Korshun, V. A., Varizhuk, A. M., & Aralov, A. V. (2025). 5′-UTR G-quadruplex-mediated translation regulation in eukaryotes: Current understanding and methodological challenges. International Journal of Molecular Sciences, 26(3), 1187.

Kruchinin, A. A., Kamzeeva, P. N., Zharkov, D. O., Aralov, A. V., & Makarova, A. V. (2024). 8-Oxoadenine: A “new” player of the oxidative stress in mammals? International Journal of Molecular Sciences, 25(2), 1342.

Kamzeeva, P., Dagaev, N., Lizunova, S., Khodarovich, Y., Sogomonyan, A., Kolchanova, A., Pokrovsky, V., Alferova, V., Chistov, A., Eshtukov-Shcheglov, A., et al. (2023). Synthesis and biological evaluation of benzo[4,5]- and naphtho[2′,1′:4,5]imidazo[1,2-c]pyrimidinone derivatives. Biomolecules, 13(11), 1669.

Knizhnik, E., Chumakov, S., Svetlova, J., Pavlova, I., Khodarovich, Y., Brylev, V., Severov, V., Alieva, R., Kozlovskaya, L., Andreev, D., et al. (2023). Unwinding the SARS-CoV-2 ribosomal frameshifting pseudoknot with LNA and G-clamp-modified phosphorothioate oligonucleotides inhibits viral replication. Biomolecules, 13(11), 1660.

Kamzeeva, P., Petushkov, I., Knizhnik, E., Snoeck, R., Khodarovich, Y., Ryabukhina, E., Alferova, V., Eshtukov-Shcheglov, A., Belyaev, E., Svetlova, J., et al. (2023). Phenotypic test of benzo[4,5]imidazo[1,2-c]pyrimidinone-based nucleoside and non-nucleoside derivatives against DNA and RNA viruses, including coronaviruses. International Journal of Molecular Sciences, 24(19), 14540.

Kamzeeva, P. N., Aralov, A. V., Alferova, V. A., & Korshun, V. A. (2023). Recent advances in molecular mechanisms of nucleoside antivirals. Current Issues in Molecular Biology, 45(8), 433.

 

Xinting Liu | Protein Expression and Purification | Best Researcher Award

Ms. Xinting Liu | Protein Expression and Purification | Best Researcher Award

Ms. Xinting Liu | Xi’an Jiaotong-Liverpool University | China

Ms. Xinting Liu is currently pursuing her Master’s degree in Biological Sciences at Xi’an Jiaotong-Liverpool University, where she has developed a strong foundation in molecular biology, cell biology, and protein structure modification. She is a diligent, cheerful, and sincere researcher with excellent communication and teamwork skills, known for her proactive attitude and passion for scientific inquiry. Proficient in protein expression, purification, and crystallization techniques, she has mastered key laboratory methods such as plasmid construction, PCR, qPCR, DNA sequencing, western blotting, SDS-PAGE analysis, and chromatography. Her research experiences include engineering and expressing the Aprataxin gene as a therapeutic candidate for neurodegenerative diseases, solving the crystal structure of Q15Z91 in complex with cyclic-diGMP, and designing Fp2Cas9 mutants to enhance genome-editing efficiency in cold-water fish. She has also gained practical experience through projects such as the Summer Undergraduate Research Fellowship, where she constructed and analyzed the structure of human adenosine monophosphate deaminase 2, and through internships in microbiological inspection and biology tutoring. As the Minister of General Affairs for the University Biological Science Club (2020–2022), she effectively coordinated departmental activities and led new members in community engagement. Skilled in bioinformatics tools, data visualization, and image editing software like Adobe Illustrator, she presents research findings professionally and clearly. Ms. Liu has authored 2 publications, with 10 citations and an h-index of 2, reflecting her growing academic impact in the field of molecular biology and protein engineering. Her technical expertise, creativity, and commitment to excellence prepare her to make meaningful contributions to future Ph.D. research in structural and molecular biosciences.

Profile: Orcid 

Featured Publications

Zhao, R., Zhu, J., Wang, J., Wang, D., Liu, X., Han, L., & Li, S. (2025). Functional characterization of Fp2Cas9, a cold-adapted type II-C CRISPR nuclease from Flavobacterium psychrophilum. International Journal of Molecular Sciences, 26(21), 10681.

Serena Travaglini | Genetics and Molecular Biology | Best Researcher Award

Dr. Serena Travaglini | Genetics and Molecular Biology | Best Researcher Award

Dr. Serena Travaglini | University of Rome Tor Vergata  | Italy

Dr. Serena Travaglini is a dedicated molecular biologist and researcher at the University of Rome “Tor Vergata” specializing in the characterization of leukemia stem cells. Born in Rome, she advanced through a strong academic trajectory in biotechnology, earning bachelor’s, master’s, and doctoral degrees from Tor Vergata University. She conducted her doctoral research under leading mentors, focusing on FLT3-ITD-mutated acute myeloid leukemia, identifying novel therapeutic targets. After completing her doctorate, she deepened her expertise in postdoctoral studies exploring CD99 as a therapeutic marker and the transcriptomic evolution of AML. Currently, she leads investigations into the role of p63 in thymoma within the Laboratory of Biochemistry and Molecular Biology. With a solid foundation in molecular biotechnology and translational medicine, Dr. Travaglini exemplifies excellence in both research innovation and academic leadership.

Profiles

Scopus
Orcid

Education and Experience

Dr. Travaglini’s academic journey reflects sustained dedication to biotechnology and translational medicine. She graduated in biotechnology and advanced to earn a master’s in medical biotechnology, followed by a PhD in biotechnology and translational medicine, all at Tor Vergata University. Her early research explored oxidative stress in neurodegenerative diseases and the molecular interplay in APL. During her doctoral studies, she investigated FLT3-ITD-mutated leukemia stem cells, pursuing actionable targets to impede relapse. Her postdoctoral work further expanded her expertise by analyzing CD99’s role in leukemic progenitor cell behavior and homing. As a researcher, she now explores p63’s involvement in thymoma, integrating molecular insights with translational goals. Her progression reflects a consistent focus on dissecting leukemic pathophysiology to inform therapeutic strategies.

Research Interests

Dr. Travaglini’s research spans the genetic and cellular characterization of leukemia, with a distinctive focus on leukemia stem cells and clonal evolution. She is deeply interested in validating genetic biomarkers in AML and APL, exploring therapeutic vulnerabilities, and understanding resistance in arsenic-trioxide-treated APL. Her work includes analysis of surface immunophenotypes including CD99, CD34, and CD123, and characterizing t(11;17)-positive AMLs. She also investigates therapy-related AML and how genetic changes drive disease progression. Her broader goals emphasize leveraging multiparameter flow cytometry, genetics, and in vivo modeling to inform precision medicine strategies that combat recurrence and treatment resistance.

Awards & Recognition

Dr. Travaglini is the recipient of notable recognitions for her contributions to life sciences research. She received the Angeletti-Mortari Life Sciences Research Prize from MSD Italia—an award honoring innovation by emerging researchers and supporting their work in scientific excellence within Italy. She also won the “AIL Beat Leukemia” Fellowship awarded by the Italian Society of Experimental Hematology, which advanced her project investigating the molecular landscape of high-risk acute promyelocytic leukemia and strategies to overcome disease progression beat-leukemia.org. These honors reflect her impactful contributions to leukemia research and her promise as a leading young scientist.

Publications Top Notes

Functional characterization and response to FLT3 inhibitors in acute myeloid leukaemia with a non‐canonical FLT3 mutation: A proof of concept

Journal: British Journal of Haematology
Authors: Serena Travaglini, Carmelo Gurnari, Silvia Antonelli, Francesco Marchesi, Gioia De Angelis, Tiziana Ottone, Mariadomenica Divona, Antonio Cristiano, Hajro Hajrullaj, Andrea Mengarelli, et al.

Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment

Journal:  Cancers 
Authors: Cristina Banella, Gianfranco Catalano, Serena Travaglini, Elvira Pelosi, Tiziana Ottone, Alessandra Zaza, Gisella Guerrera, Daniela Francesca Angelini, Pasquale Niscola, Mariadomenica Divona, et al.

From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression

Journal: Biology 
Authors: Carmelo Gurnari, Emiliano Fabiani, Giulia Falconi, Serena Travaglini, Tiziana Ottone, Antonio Cristiano, Maria Teresa Voso.

PML/RARa Interferes with NRF2 Transcriptional Activity Increasing the Sensitivity to Ascorbate of Acute Promyelocytic Leukemia Cells

Journal: Cancers 
Authors: Cristina Banella, Gianfranco Catalano, Serena Travaglini, Mariadomenica Divona, Silvia Masciarelli, Gisella Guerrera, Francesco Fazi, Francesco Lo-Coco, Maria Teresa Voso, Nelida Ines Noguera.

Conclusion

Dr. Serena Travaglini stands as a distinguished emerging researcher in molecular hematology, demonstrating both scientific rigor and translational vision. Her academic excellence, from her foundational training through her innovative postdoctoral and current work, underscores her commitment to unraveling the biological mechanisms underpinning leukemia and resistance. Her strategically focused research on leukemia stem cells, therapeutic biomarker validation, and overcoming drug-resistant APL speaks to her potential to influence next-generation leukemia therapies. Recognition through prestigious awards and notable scholarly contributions further affirm her candidacy. With continued support, Dr. Travaglini is poised to lead impactful research initiatives that can reshape treatment paradigms in acute leukemia and precision medicine.

Saloni Sinha | Biochemistry | Best Researcher Award

Dr. Saloni Sinha | Biochemistry | Best Researcher Award

Dr. Saloni Sinha | Weill Cornell Medicine | United States

Dr. Saloni Sinha is a dedicated biomedical researcher currently serving as a Research Associate at a prominent medical college in New York. With a strong foundation shaped by her doctoral studies in biological sciences from a leading Indian research institution, she has progressed through postdoctoral roles in renowned laboratories, contributing to her growing expertise in liver biology and immune regulation. Her work spans from fundamental mechanisms in hematopoietic stem cell biology to in vivo models of viral infection and liver disease. Over the years, her collaborative spirit and scientific rigor have earned her recognition both in the United States and her native country. She combines a deep curiosity with methodological precision, making her a rising figure in translational biomedical research, particularly at the interface of inflammation, aging, and organ function.

Profiles

ORCID

GOOGLE SCHOLAR

Education

Dr. Saloni’s academic journey began with an honours degree in microbiology from a distinguished college in Kolkata, where her interest in cellular biology took root. She then advanced to earn a master’s degree in biological sciences at a leading Indian research centre, where her work under a notable mentor laid the groundwork for her fascination with stem cell regulation and developmental mechanisms. This path naturally progressed into a doctoral program at the same research centre, where she explored the conserved roles of specialized domain proteins in blood cell homeostasis across model systems. The educational environment she experienced was rigorous and research-intensive, honing both her experimental skills and scientific reasoning. These formative years not only forged her technical foundation, but also instilled a passion for uncovering molecular pathways that govern health and disease, setting the stage for her subsequent research career.

Experience

Dr. Saloni embarked on a postdoctoral journey at a prestigious university in the United States, where she refined her expertise in immunology under the guidance of an established professor. She later transitioned to a prominent medical research institution in New York, embarking on a second postdoctoral appointment where she delved deeply into liver biology, inflammation, and aging processes. Her steadfast contributions in that setting led to her current role as a research associate in medicine, where she continues to advance translational studies using both in vitro and in vivo models. Alongside her research responsibilities, she mentors undergraduate interns, contributes as a teaching assistant in graduate courses, and takes part in editorial and peer review activities for a variety of scientific journals, demonstrating a well-rounded engagement with the academic and research community.

Research Interests

Dr. Saloni’s work centers on the interplay between aging, inflammation, and liver health. She investigates how age-related changes in hepatocyte organization and intercellular communication contribute to organ dysfunction, with an eye toward epithelial and fibrotic pathology. Her projects also explore epigenetic strategies to mitigate liver fibrosis and cancer risk, including the potential repurposing of existing therapeutics to alter disease trajectories in aging tissues. Another facet of her research examines innate immune signaling pathways in hematopoiesis as mechanisms of viral defense, notably in the context of lesser-known but emerging pathogens. Together, her interests unify organ-level physiology, molecular signaling, immune modulation, and translational therapeutic avenues. This integrated approach seeks to yield insights into disease prevention and treatment, particularly in age-susceptible populations.

Awards and Recognition

Dr. Saloni’s scientific promise has been acknowledged through several prestigious recognitions. Among these, she received a pilot research award at her current institution in the United States for her exploration of epigenetic regulation of liver inflammation and fibrosis. Her achievements were also recognized nationally in India with a young scientist medal awarded by a leading academy that celebrates emerging promise, creativity, and excellence in early-career investigators. Earlier in her career, she was invited to present her work at an inspiring research symposium at her doctoral institution. During her doctoral years, she also earned accolades for poster presentations at faculty and in-house symposia. These honors reflect both the novelty and impactful nature of her research contributions, as well as her ability to communicate scientific ideas effectively to diverse academic audiences.

Publication Top Notes

Repurposing GLP-1 Receptor Agonists: A Perspective on Epigenetic Strategies to Combat Fibrosis and Hepatocellular Carcinoma in the Aged Liver

Journal: Cancers (2025-08-08)
Authors: Silvia Hanna, Jason Sethiadi, Qazi Ali, Saloni Sinha

Liver-specific Mettl14 deletion induces nuclear heterotypia and dysregulates RNA export machinery

Journal: Preprint (2024-06-17)
Authors: Keith A Berggren, Saloni Sinha, Aaron E Lin, Michael P Schwoerer, Stephanie Maya, Abhishek Biswas, Thomas R Cafiero, Yongzhen Liu, Hans P Gertje, Saori Suzuki et al.

Mesenteric Parametrial Fat Pad Surgery for in vivo Implantation of Hepatocytes in Nude Mice

Journal: BIO-PROTOCOL (2024-01-04)
Authors: Saloni Sinha, Duc-Huy Nguyen, Nora Hassan, Qazi Ali, Jason Sethiadi, Sergey Tsoy, Robert Schwartz

Organelle stress and alterations in interorganelle crosstalk during liver fibrosis

Journal: Hepatology (Baltimore, Md.) (2023-01-03)
Authors: Sinha S, Hassan N, Schwartz RE

Dual-Reporter System for Real-Time Monitoring of SARS-CoV-2 Main Protease Activity in Live Cells Enables Identification of an Allosteric Inhibition Path

Journal: ACS Bio & Med Chem Au (2022-10-17)
Authors: Bram Y, Duan X, Nilsson-Payant BE, Chandar V, Wu H, Shore D, Fajardo A, Sinha S, Hassan N, Weinstein H et al.

Conclusion

Dr. Saloni Sinha is a dynamic researcher whose career trajectory bridges foundational biological inquiry with translational prospects aimed at enhancing liver health and immune resilience. Her academic training and postdoctoral experiences have equipped her with a sophisticated toolkit, while her research output reflects both depth and relevance in contemporary biomedical challenges. Honored by institutions in two countries, she continues to engage with the scientific community through publications, mentorship, editorial service, and presenting her findings. She stands poised to contribute meaningfully to the development of therapeutic strategies that target aging-related diseases, with her work offering valuable insights into organ homeostasis, inflammation, and regenerative potential.